瑞舒伐他汀和阿托伐他汀在早发冠心病急性心肌梗死患者治疗中近期（基础医学范文）.docVIP

瑞舒伐他汀和阿托伐他汀在早发冠心病急性心肌梗死患者治疗中近期（基础医学范文） 文档信息 属性： F-00NN28，doc格式，正文6486字。质优实惠，欢迎下载！ 适用： 作为文章写作的参考文献，解决如何写好实用应用文、正确编写文案格式、内容摘取等相关工作。 作者： 佚名 目录 TOC \o 1-9 \h \z \u 目录 1 正文 1 搞要 1 关键字：瑞舒伐他汀；阿托伐他汀；冠心病；急性心肌梗死；心血管事件 2 1 资料与方法 3 2 结果 4 3 讨论 5 [参考文献] 8 论文原创声明（模板） 10 论文致谢（模板） 11 正文 瑞舒伐他汀和阿托伐他汀在早发冠心病急性心肌梗死患者治疗中近期（基础医学范文） 搞要 摘要：目的探讨瑞舒伐他汀和阿托伐他汀在早发冠心病急性心肌梗死患者治疗中近期疗效。方法选择早发冠心病急性心肌梗死患者60例为研究对象，随机分为阿托伐他汀组和瑞舒伐他汀组各30例。阿托伐他汀组给予阿托伐他汀治疗，瑞舒伐他汀组采用瑞舒伐他汀钙治疗。治疗6个月后，比较两组治疗前后血脂水平、hs-CRP水平，血管内皮功能以及心脏功能。结果治疗后，两组患者TC、TG、LDL-C、hs-CRP均显著下降，而HDL-C显著升高（P）。治疗后，瑞舒伐他汀组TC、hs-CRP水平显著低于阿托伐他汀组（P）。治疗后两组LVEF、FMD显著增加（P或P）。结论早发冠心病急性心肌梗死患者给予瑞舒伐他汀和阿托伐他汀调节血脂治疗，均能显著改善患者血脂水平，降低心血管事件风险几率 关键字：瑞舒伐他汀；阿托伐他汀；冠心病；急性心肌梗死；心血管事件 [中图分类号] [文献标识码] B [文章编号] 1673-9701（2015）26-0099-04 Term effect of Rosuvastatin and Atorvastatin for premature acute myocardial infarction ZHAO Wenyi HU Zhongyao REN Deng The Second Ward of Cardiology Department， Zhumadian First Peoples Hospital in Henan Province， Zhumadian 463000， China [Abstract] Objective To discuss the term effect of Rosuvastatin and Atorvastatin for Premature acute myocardial infarction. Methods 60 cases with premature acute myocardial infarction were selected and randomly divided into Atorvastatin group and Rosuvastatin group， with each of 30 cases. Atorvastatin group was treated with Atorvastatin， and Rosuvastatin group was treated with Rosuvastatin group. After 6 month of treatment， lipid level， hs-CRP level， vascular endothelial function and heart function of two groups were compared. Results After treatment， TC、TG、LDL-C、hs-CRP of two group were lower， and HDL was higher（P）. After treatment， TC、hs-CRP of Rosuvastatin group was lower than Atorvastatin group（P）. After treatment， LVEF and FMD of two groups were higher（P or P）. Conclusion Rosuvastatin and Atorvastatin for premature acute myocardial infarction can improve blood lipid levels， and reduce the risk of cardiovascular events probability. [Key words] Rosuvastatin； Atorvastatin； Coronary arter